Fecal Microbiota Transplant Program

The Fecal Microbiota Transplant Program was established in 2013 and was implemented to address the rising number of patients being diagnosed with recurrent Clostridium difficile infection, also called CDI or C. diff., a serious bacterial infection that can cause inflammation of the colon, diarrhea, fever, and abdominal cramps, and can sometimes result in death. C. diff primarily occurs when the indigenous bacteria in a person’s gut is removed by an antibiotic being used to treat a separate condition, thereby hindering the body’s ability to fight off C. diff.

Fecal Microbiota Transplant (FMT) is a procedure where healthy fecal material is placed into a person infected with C. diff. The goal of the FMT procedure is to repopulate the colon with healthy bacteria in the infected person and cure them of C. diff. In 2017, our program successfully treated approximately 30 patients who were experiencing reoccurring C. diff.

The program team currently consists of a pharmacist and nearly 10 physicians coming from the Divisions of Infectious Diseases and Gastroenterology and Hepatology, and is directed by Krishna Rao, MD, MS.